Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) requiring piperazine scaffolds. Its protected amine group allows for selective reactions in multi-step organic syntheses. Commonly employed in medicinal chemistry for constructing drug candidates targeting central nervous system disorders and metabolic diseases. Also utilized in research settings for generating compound libraries in drug discovery programs.